A 32-year-old woman presents with a 16-hour history of severe headache, fever, photophobia, and neck stiffness. She appears unwell but is alert and oriented. Vital signs: temperature 39.1°C, blood pressure 118/75 mmHg, heart rate 105 bpm. There are no focal neurological signs or papilloedema. CT head performed prior to lumbar puncture is normal. Lumbar puncture shows: opening pressure 26 cmH2O, CSF white cells 1,450/mm³ (88% neutrophils), protein 1.9 g/L, glucose 2.4 mmol/L (serum glucose 6.2 mmol/L). Gram stain shows Gram-positive cocci in chains. Which one of the following organisms is most likely responsible?
Q12
A 45-year-old man from Georgia (country in the Caucasus) presents with an 11-week history of cough, fever, and weight loss. Chest X-ray shows bilateral upper zone cavitation. Sputum smear is positive for acid-fast bacilli. Culture confirms Mycobacterium tuberculosis, and molecular testing shows resistance to rifampicin and isoniazid, but sensitivity to fluoroquinolones and second-line injectable agents. He has no other medical conditions and normal renal function. According to current WHO guidelines for multidrug-resistant tuberculosis (MDR-TB), which one of the following is the minimum recommended total treatment duration?
Q13
A 9-month-old infant is brought to the emergency department with a 10-hour history of fever, poor feeding, and irritability. The infant was born at term with no complications but has not received any vaccinations due to parental choice. On examination, temperature is 39.2°C, heart rate 165 bpm, respiratory rate 45/min, blood pressure 75/50 mmHg. The infant is lethargic with a bulging anterior fontanelle. Capillary refill time is 3 seconds. Blood tests show: white cells 22.1 × 10⁹/L (neutrophils 18.5 × 10⁹/L), CRP 145 mg/L. Lumbar puncture shows: CSF white cells 4,800/mm³ (92% neutrophils), protein 3.2 g/L, glucose 0.8 mmol/L (serum glucose 4.5 mmol/L). Which one of the following organisms is most likely responsible?
Q14
A 41-year-old man from Afghanistan with newly diagnosed drug-sensitive pulmonary tuberculosis is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. He has no other medical conditions and takes no regular medications. At his 4-week review, he is clinically improving but complains of painful, swollen joints in his feet. On examination, his first metatarsophalangeal joints are erythematous, warm, and exquisitely tender bilaterally. His serum uric acid level is 620 micromol/L (normal range 200-430 micromol/L). Which one of the following is the most appropriate management?
Q15
A 63-year-old woman with a history of breast cancer treated with mastectomy 5 years ago presents with a 6-week history of progressive confusion and personality change. Her husband reports she has become withdrawn and forgetful. On examination, temperature is 37.6°C, Glasgow Coma Scale is 14/15 (E4V4M6), and she has subtle left-sided weakness. CT head shows a ring-enhancing lesion in the right frontal lobe with surrounding oedema. Lumbar puncture shows: opening pressure 24 cmH2O, CSF white cells 180/mm³ (70% lymphocytes), protein 1.8 g/L, glucose 2.3 mmol/L (serum glucose 5.8 mmol/L). Gram stain and initial bacterial cultures are negative. Which one of the following is the most likely diagnosis?
Q16
According to current UK Public Health England guidance on tuberculosis contact tracing, which one of the following scenarios requires chemoprophylaxis for latent tuberculosis infection to be offered to exposed contacts, regardless of the Mantoux test or interferon-gamma release assay (IGRA) result?
Q17
A 52-year-old man with newly diagnosed smear-positive pulmonary tuberculosis is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. He has a history of schizophrenia and is taking clozapine 400 mg daily, which has achieved good symptom control. Three weeks after starting TB treatment, his community psychiatric nurse contacts you reporting that he has developed auditory hallucinations and persecutory delusions. His clozapine level is 180 mcg/L (therapeutic range 350-600 mcg/L). Which one of the following best explains this presentation?
Q18
A 5-year-old boy who recently emigrated from Pakistan presents with a 5-week history of progressive lethargy, low-grade fever, and behavioural changes. His parents report he has become increasingly irritable and has difficulty walking. On examination, temperature is 37.8°C, he has neck stiffness and bilateral sixth nerve palsies. CT head shows basal meningeal enhancement and hydrocephalus. Lumbar puncture shows: opening pressure 35 cmH2O, CSF white cells 250/mm³ (80% lymphocytes), protein 3.2 g/L, glucose 1.8 mmol/L (serum glucose 5.4 mmol/L). Ziehl-Neelsen stain of CSF is negative. What is the most appropriate initial antimicrobial regimen?
Q19
A 27-year-old woman presents with a 10-hour history of severe headache, photophobia, and vomiting. On examination, temperature is 38.9°C, blood pressure 105/68 mmHg, heart rate 118 bpm. She has marked neck stiffness and a positive Kernig's sign. A non-blanching purpuric rash is noted on her lower limbs. Lumbar puncture shows: opening pressure 28 cmH2O, CSF white cells 3,200/mm³ (95% neutrophils), protein 2.8 g/L, glucose 1.2 mmol/L (serum glucose 6.1 mmol/L). Gram stain shows Gram-negative diplococci. Which one of the following should be administered immediately after blood cultures are obtained?
Q20
A 34-year-old man from Romania with newly diagnosed smear-positive pulmonary tuberculosis is started on standard four-drug therapy. He has no significant past medical history. After 3 days of treatment, he develops a red, itchy maculopapular rash over his trunk and limbs, with no mucosal involvement or systemic features. His vital signs are normal. Which one of the following is the most appropriate initial management?
Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs
Question 11: A 32-year-old woman presents with a 16-hour history of severe headache, fever, photophobia, and neck stiffness. She appears unwell but is alert and oriented. Vital signs: temperature 39.1°C, blood pressure 118/75 mmHg, heart rate 105 bpm. There are no focal neurological signs or papilloedema. CT head performed prior to lumbar puncture is normal. Lumbar puncture shows: opening pressure 26 cmH2O, CSF white cells 1,450/mm³ (88% neutrophils), protein 1.9 g/L, glucose 2.4 mmol/L (serum glucose 6.2 mmol/L). Gram stain shows Gram-positive cocci in chains. Which one of the following organisms is most likely responsible?
A. Streptococcus pneumoniae (Correct Answer)
B. Streptococcus agalactiae (Group B Streptococcus)
C. Enterococcus faecalis
D. Streptococcus pyogenes (Group A Streptococcus)
E. Viridans group streptococci
Explanation: ***Streptococcus pneumoniae***
- This organism is the **most common cause of community-acquired bacterial meningitis** in adults, fitting the patient's acute presentation with fever, headache, photophobia, and neck stiffness.
- The CSF findings (high neutrophils, elevated protein, low glucose) are classic for **bacterial meningitis**, and while often described as diplococci, *S. pneumoniae* can appear as **Gram-positive cocci in chains** on Gram stain.
*Streptococcus agalactiae (Group B Streptococcus)*
- While a significant cause of meningitis, it primarily affects **neonates** and, less commonly, immunocompromised or elderly adults.
- A healthy 32-year-old woman is not typically at high risk for GBS meningitis unless specific risk factors like **pregnancy** or severe underlying disease are present.
*Enterococcus faecalis*
- Meningitis due to *Enterococcus faecalis* is uncommon and usually associated with specific risk factors such as recent **neurosurgery**, head trauma, or **CSF shunts**.
- It is a rare cause of primary community-acquired bacterial meningitis in an otherwise healthy individual, despite being a Gram-positive coccus.
*Streptococcus pyogenes (Group A Streptococcus)*
- *S. pyogenes* is a very rare cause of meningitis and typically occurs as a secondary complication of a primary infection such as **otitis media**, sinusitis, or mastoiditis.
- The clinical picture in this case is a primary acute bacterial meningitis, making *S. pneumoniae* statistically much more likely.
*Viridans group streptococci*
- These organisms are generally low-virulence commensals of the oral cavity and are typically associated with meningitis only in specific settings, such as following **neurosurgery** or in patients with **infective endocarditis**.
- They are not a common cause of acute, severe community-acquired meningitis in a healthy young adult, unlike *S. pneumoniae*.
Question 12: A 45-year-old man from Georgia (country in the Caucasus) presents with an 11-week history of cough, fever, and weight loss. Chest X-ray shows bilateral upper zone cavitation. Sputum smear is positive for acid-fast bacilli. Culture confirms Mycobacterium tuberculosis, and molecular testing shows resistance to rifampicin and isoniazid, but sensitivity to fluoroquinolones and second-line injectable agents. He has no other medical conditions and normal renal function. According to current WHO guidelines for multidrug-resistant tuberculosis (MDR-TB), which one of the following is the minimum recommended total treatment duration?
A. 9 months
B. 12 months
C. 15 months
D. 18 months (Correct Answer)
E. 24 months
Explanation: ***18 months***
- The WHO recommends a total treatment duration of **18 to 20 months** for patients with **multidrug-resistant TB (MDR-TB)** who are receiving longer all-oral regimens.
- This duration is preferred in cases with **extensive pulmonary disease**, such as the bilateral cavitation seen in this patient, to ensure complete eradication and prevent relapse.
*9 months*
- While a **shorter 9-11 month regimen** exists for MDR-TB, it is typically reserved for patients without **extensive cavitation** or specific resistance patterns.
- This patient's bilateral upper zone cavitation indicates a high bacterial load, often disqualifying them from the shorter treatment protocol under standard guidelines.
*12 months*
- A **12-month duration** is not a standard recommended minimum for conventional or established shorter **MDR-TB** treatment protocols.
- Most standardized regimens for **rifampicin-resistant TB** are either shorter (9-11 months) or longer (18+ months).
*15 months*
- **15 months** is considered insufficient for the longer regimen, which requires at least **15-17 months** of treatment after **culture conversion**.
- Using a shorter-than-recommended duration for MDR-TB significantly increases the risk of acquiring further resistance to **fluoroquinolones**.
*24 months*
- While treatment may be extended to **24 months** in cases of delayed culture conversion, **18 months** is the minimum recommended duration for the longer regimen.
- **24 months** is generally the upper limit of the recommended range rather than the minimum standard for a patient with normal renal function and no prior treatment failure.
Question 13: A 9-month-old infant is brought to the emergency department with a 10-hour history of fever, poor feeding, and irritability. The infant was born at term with no complications but has not received any vaccinations due to parental choice. On examination, temperature is 39.2°C, heart rate 165 bpm, respiratory rate 45/min, blood pressure 75/50 mmHg. The infant is lethargic with a bulging anterior fontanelle. Capillary refill time is 3 seconds. Blood tests show: white cells 22.1 × 10⁹/L (neutrophils 18.5 × 10⁹/L), CRP 145 mg/L. Lumbar puncture shows: CSF white cells 4,800/mm³ (92% neutrophils), protein 3.2 g/L, glucose 0.8 mmol/L (serum glucose 4.5 mmol/L). Which one of the following organisms is most likely responsible?
A. Streptococcus pneumoniae (Correct Answer)
B. Neisseria meningitidis
C. Haemophilus influenzae type b
D. Group B Streptococcus
E. Listeria monocytogenes
Explanation: ***Streptococcus pneumoniae***- This is currently the most common cause of **bacterial meningitis** in children aged 2 months to 5 years, especially in **unvaccinated individuals**.- The CSF profile showing **neutrophilic pleocytosis**, high protein, and **severely low glucose** (ratio < 0.2) is classic for this aggressive pathogen.*Neisseria meningitidis*- While a very common cause of meningitis in this age group, it often presents with a characteristic **non-blanching purpuric rash**, which is not mentioned.- Although it causes similar CSF changes, **Streptococcus pneumoniae** remains slightly more prevalent in the specific pediatric context of non-immunization.*Haemophilus influenzae type b*- This was a leading cause in infants prior to the introduction of the **Hib vaccine**; however, it is less common than pneumococcus even in unvaccinated populations.- While technically possible in an unvaccinated child, **Streptococcus pneumoniae** is statistically more likely to cause severe meningitis in this age bracket today.*Group B Streptococcus*- This organism is a leading cause of neonatal meningitis but typically occurs in the **first 3 months** of life (early and late-onset disease).- It is a very unlikely cause for a **9-month-old** infant who has moved past the typical window for vertical transmission or maternal colonization risks.*Listeria monocytogenes*- This pathogen primarily affects **neonates** (under 1 month), the elderly, or those who are **immunocompromised**.- A healthy 9-month-old infant is not the typical demographic for *Listeria*, and the CSF profile usually shows a more mixed or **mononuclear** cell response.
Question 14: A 41-year-old man from Afghanistan with newly diagnosed drug-sensitive pulmonary tuberculosis is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. He has no other medical conditions and takes no regular medications. At his 4-week review, he is clinically improving but complains of painful, swollen joints in his feet. On examination, his first metatarsophalangeal joints are erythematous, warm, and exquisitely tender bilaterally. His serum uric acid level is 620 micromol/L (normal range 200-430 micromol/L). Which one of the following is the most appropriate management?
A. Continue all anti-tuberculous medications and start allopurinol 100 mg daily
B. Stop pyrazinamide and replace with levofloxacin 750 mg daily
C. Continue all anti-tuberculous medications and start colchicine 500 mcg twice daily (Correct Answer)
D. Stop ethambutol and continue with rifampicin, isoniazid, and pyrazinamide only
E. Continue all anti-tuberculous medications and start prednisolone 30 mg daily
Explanation: ***Continue all anti-tuberculous medications and start colchicine 500 mcg twice daily***
- The patient's symptoms (painful, swollen, erythematous, tender first MTP joints, elevated **serum uric acid**) are classic for **acute gout**, which is a known side effect of **pyrazinamide** due to inhibited renal uric acid excretion.
- The most appropriate management is to treat the acute flare symptomatically with an anti-inflammatory agent like **colchicine** or NSAIDs, while continuing the critical **anti-tuberculous regimen** to ensure effective treatment of TB.
*Continue all anti-tuberculous medications and start allopurinol 100 mg daily*
- **Allopurinol** is a urate-lowering drug for chronic gout management and **prophylaxis**, but initiating it during an **acute gout attack** can worsen or prolong the flare.
- It does not provide immediate relief from the **acute inflammation** and pain, which requires specific anti-inflammatory treatment.
*Stop pyrazinamide and replace with levofloxacin 750 mg daily*
- **Pyrazinamide** is an essential component of the **intensive phase** of drug-sensitive TB treatment, and its removal would significantly prolong the total duration of therapy.
- Replacing it with a **fluoroquinolone** like levofloxacin is typically reserved for cases where first-line drugs are truly intolerable or in instances of drug resistance, not for manageable side effects like acute gout.
*Stop ethambutol and continue with rifampicin, isoniazid, and pyrazinamide only*
- **Ethambutol** is primarily associated with **optic neuritis** as a key adverse effect, not hyperuricemia or gouty arthritis.
- Discontinuing ethambutol would not address the underlying cause of the patient's **acute gout flare**, which is attributed to pyrazinamide.
*Continue all anti-tuberculous medications and start prednisolone 30 mg daily*
- While **systemic corticosteroids** can effectively treat acute gout, they are generally considered a second-line option after **colchicine** or NSAIDs for localized flares.
- Using high-dose **prednisolone** in a patient with active **pulmonary tuberculosis** requires careful consideration due to its potential **immunosuppressive effects**, which might compromise TB control.
Question 15: A 63-year-old woman with a history of breast cancer treated with mastectomy 5 years ago presents with a 6-week history of progressive confusion and personality change. Her husband reports she has become withdrawn and forgetful. On examination, temperature is 37.6°C, Glasgow Coma Scale is 14/15 (E4V4M6), and she has subtle left-sided weakness. CT head shows a ring-enhancing lesion in the right frontal lobe with surrounding oedema. Lumbar puncture shows: opening pressure 24 cmH2O, CSF white cells 180/mm³ (70% lymphocytes), protein 1.8 g/L, glucose 2.3 mmol/L (serum glucose 5.8 mmol/L). Gram stain and initial bacterial cultures are negative. Which one of the following is the most likely diagnosis?
A. Brain metastasis from breast cancer
B. Tuberculous meningitis with tuberculoma (Correct Answer)
C. Cerebral toxoplasmosis
D. Herpes simplex encephalitis
E. Cryptococcal meningitis
Explanation: ***Tuberculous meningitis with tuberculoma***
- The 6-week progressive course and classic CSF findings of **lymphocytic pleocytosis**, **elevated protein**, and **markedly low glucose** (CSF/serum glucose ratio <0.5) are highly indicative of tuberculous meningitis.
- The presence of a **ring-enhancing lesion** with surrounding edema on CT head, alongside these CSF findings, is characteristic of a cerebral tuberculoma, a common manifestation of CNS tuberculosis.
*Brain metastasis from breast cancer*
- While the patient has a history of breast cancer and ring-enhancing lesions can be metastases, this diagnosis does not explain the significant **inflammatory CSF profile** with high white cell count and protein.
- Metastases typically do not cause **meningeal inflammation** leading to a marked lymphocytic pleocytosis and low CSF glucose unless there is extensive leptomeningeal carcinomatosis, which has a distinct clinical presentation.
*Cerebral toxoplasmosis*
- This condition is almost exclusively seen in **severely immunocompromised** individuals, particularly those with HIV/AIDS and low CD4 counts, which is not indicated here.
- Toxoplasmosis typically presents with **multiple ring-enhancing lesions**, often in the basal ganglia, whereas this patient has a single lesion and a CSF profile more consistent with tuberculosis.
*Herpes simplex encephalitis*
- This encephalitis typically presents with an **acute onset** (days, not weeks) and has a predilection for the **temporal lobes**, often causing focal seizures, aphasia, or personality changes.
- While CSF shows lymphocytic pleocytosis and elevated protein, **CSF glucose is usually normal**, unlike the very low glucose observed in this patient.
*Cryptococcal meningitis*
- This fungal meningitis primarily affects **immunocompromised hosts** (e.g., HIV/AIDS, organ transplant recipients), which is not the case for this patient.
- While it can cause CSF changes similar to TB (lymphocytic pleocytosis, low glucose, high protein), a **solitary large ring-enhancing lesion** is less typical, and diagnosis often requires India ink stain or cryptococcal antigen testing.
Question 16: According to current UK Public Health England guidance on tuberculosis contact tracing, which one of the following scenarios requires chemoprophylaxis for latent tuberculosis infection to be offered to exposed contacts, regardless of the Mantoux test or interferon-gamma release assay (IGRA) result?
A. A 35-year-old immunocompetent adult exposed to smear-negative, culture-positive pulmonary TB
B. A 4-year-old child exposed to smear-positive pulmonary TB in the household (Correct Answer)
C. A 28-year-old healthcare worker exposed to a patient with cavitating pulmonary TB for 2 hours without appropriate PPE
D. A 45-year-old man with type 2 diabetes exposed to smear-positive pulmonary TB for 8 hours in a poorly ventilated room
E. A 32-year-old HIV-positive patient (CD4 350 cells/mm³) exposed to drug-resistant TB for 3 hours
Explanation: ***A 4-year-old child exposed to smear-positive pulmonary TB in the household***- Children **under 5 years of age** who are household contacts of **smear-positive pulmonary TB** must receive chemoprophylaxis regardless of initial test results due to high risk of rapid progression.- This approach covers the **window period** where initial Mantoux or IGRA may be negative despite recent infection, preventing severe outcomes like **TB meningitis**.*A 35-year-old immunocompetent adult exposed to smear-negative, culture-positive pulmonary TB*- For **immunocompetent adults**, chemoprophylaxis for **latent TB** is only indicated if the Mantoux test or IGRA is positive.- Smear-negative cases are considered **less infectious** than smear-positive cases, reducing the immediate urgency for empiric treatment in healthy adults.*A 28-year-old healthcare worker exposed to a patient with cavitating pulmonary TB for 2 hours without appropriate PPE*- Guidance for healthcare workers requires **screening with IGRA or Mantoux** following a significant exposure before initiating treatment.- **Chemoprophylaxis** is only offered if evidence of latent infection is found during the follow-up testing at 6-12 weeks.*A 45-year-old man with type 2 diabetes exposed to smear-positive pulmonary TB for 8 hours in a poorly ventilated room*- While diabetes is a risk factor, **immunocompetent adults** still require a positive screening test result to justify starting chemoprophylaxis.- Routine practice involves performing a **Mantoux or IGRA** first and treating only if these indicate latent tuberculosis.*A 32-year-old HIV-positive patient (CD4 350 cells/mm³) exposed to drug-resistant TB for 3 hours*- Empiric chemoprophylaxis for HIV-positive contacts is generally reserved for those with **CD4 counts <200 cells/mm³** or other significant immunosuppression.- With a **CD4 count of 350**, this patient would typically undergo standard IGRA/Mantoux testing rather than receiving immediate prophylaxis regardless of result.
Question 17: A 52-year-old man with newly diagnosed smear-positive pulmonary tuberculosis is started on rifampicin, isoniazid, pyrazinamide, and ethambutol. He has a history of schizophrenia and is taking clozapine 400 mg daily, which has achieved good symptom control. Three weeks after starting TB treatment, his community psychiatric nurse contacts you reporting that he has developed auditory hallucinations and persecutory delusions. His clozapine level is 180 mcg/L (therapeutic range 350-600 mcg/L). Which one of the following best explains this presentation?
A. Isoniazid has directly neurotoxic effects causing psychosis
B. Rifampicin has induced hepatic enzymes, reducing clozapine levels (Correct Answer)
C. Ethambutol has crossed the blood-brain barrier and caused CNS toxicity
D. Pyrazinamide has competed with clozapine for protein binding sites
E. The patient has developed tuberculous meningitis with neuropsychiatric manifestations
Explanation: ***Rifampicin has induced hepatic enzymes, reducing clozapine levels***
- **Rifampicin** is a potent inducer of the **cytochrome P450 system** (specifically CYP1A2 and CYP3A4), which are the primary enzymes responsible for metabolizing **clozapine**.
- This induction increases **clozapine clearance**, resulting in the subtherapeutic level of **180 mcg/L** and the subsequent relapse of psychotic symptoms like **hallucinations and delusions**.
*Isoniazid has directly neurotoxic effects causing psychosis*
- While **isoniazid** can cause peripheral neuropathy or rare neuropsychiatric side effects, it typically does so through **pyridoxine (Vitamin B6) deficiency**.
- This mechanism does not account for the laboratory finding of **low clozapine levels**, which is the primary driver of this patient's relapse.
*Ethambutol has crossed the blood-brain barrier and caused CNS toxicity*
- **Ethambutol** is primarily known for **optic neuritis** (painless blurred vision and red-green color blindness) rather than global CNS toxicity or psychosis.
- It does not significantly alter the **metabolic pathways** or serum concentrations of antipsychotic medications like clozapine.
*Pyrazinamide has competed with clozapine for protein binding sites*
- Displacement from **protein binding sites** would theoretically increase the free (active) fraction of a drug, potentially leading to **toxicity**, not the low levels seen here.
- **Pyrazinamide** does not have a clinically significant interaction with clozapine regarding **protein binding** or hepatic enzyme modulation.
*The patient has developed tuberculous meningitis with neuropsychiatric manifestations*
- **Tuberculous meningitis** typically presents with systemic symptoms like **fever**, headache, neck stiffness, and cranial nerve palsies.
- While it can causes altered mental status, it would not cause a specific **decrease in clozapine serum concentration** to subtherapeutic levels.
Question 18: A 5-year-old boy who recently emigrated from Pakistan presents with a 5-week history of progressive lethargy, low-grade fever, and behavioural changes. His parents report he has become increasingly irritable and has difficulty walking. On examination, temperature is 37.8°C, he has neck stiffness and bilateral sixth nerve palsies. CT head shows basal meningeal enhancement and hydrocephalus. Lumbar puncture shows: opening pressure 35 cmH2O, CSF white cells 250/mm³ (80% lymphocytes), protein 3.2 g/L, glucose 1.8 mmol/L (serum glucose 5.4 mmol/L). Ziehl-Neelsen stain of CSF is negative. What is the most appropriate initial antimicrobial regimen?
A. Rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months, then rifampicin and isoniazid for 10 months (Correct Answer)
B. Rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months, then rifampicin and isoniazid for 4 months
C. Rifampicin, isoniazid, pyrazinamide, and moxifloxacin for 2 months, then rifampicin and isoniazid for 10 months
D. Rifampicin, isoniazid, and pyrazinamide for 2 months, then rifampicin and isoniazid for 10 months
E. Rifampicin, isoniazid, ethambutol, and levofloxacin for 2 months, then rifampicin and isoniazid for 4 months
Explanation: ***Rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months, then rifampicin and isoniazid for 10 months***- The clinical presentation, including **basal meningeal enhancement**, **hydrocephalus**, **cranial nerve palsies**, and characteristic **CSF findings** (lymphocytic pleocytosis, high protein, low glucose), is highly suggestive of **Tuberculous Meningitis (TBM)**.- TBM requires a prolonged treatment course of **12 months** (2 months intensive 4-drug phase followed by 10 months continuation phase) due to the severity and difficulty of drug penetration into the **central nervous system**.*Rifampicin, isoniazid, pyrazinamide, and ethambutol for 2 months, then rifampicin and isoniazid for 4 months*- This 6-month regimen is typically used for **pulmonary tuberculosis** and is inadequate for the treatment of **Tuberculous Meningitis**.- Shorter treatment durations in TBM are associated with increased risk of **relapse** and poorer neurological outcomes.*Rifampicin, isoniazid, pyrazinamide, and moxifloxacin for 2 months, then rifampicin and isoniazid for 10 months*- **Moxifloxacin** is a fluoroquinolone generally reserved for **multidrug-resistant TB** or when first-line drugs are contraindicated, not as a standard first-line agent.- **Ethambutol** is the preferred fourth drug in the initial intensive phase for drug-sensitive TBM due to its effectiveness and favorable side effect profile.*Rifampicin, isoniazid, and pyrazinamide for 2 months, then rifampicin and isoniazid for 10 months*- A **four-drug regimen** is essential in the initial intensive phase of TBM to ensure adequate empiric coverage and prevent the development of **drug resistance**.- Omitting the fourth drug (like ethambutol or streptomycin) can lead to treatment failure, especially if there is underlying **isoniazid resistance**.*Rifampicin, isoniazid, ethambutol, and levofloxacin for 2 months, then rifampicin and isoniazid for 4 months*- This regimen incorrectly omits **pyrazinamide**, which is a crucial first-line drug with excellent **CSF penetration** and sterilizing activity against *M. tuberculosis*.- The total duration of 6 months is also insufficient for treating **Tuberculous Meningitis**, which requires a longer course.
Question 19: A 27-year-old woman presents with a 10-hour history of severe headache, photophobia, and vomiting. On examination, temperature is 38.9°C, blood pressure 105/68 mmHg, heart rate 118 bpm. She has marked neck stiffness and a positive Kernig's sign. A non-blanching purpuric rash is noted on her lower limbs. Lumbar puncture shows: opening pressure 28 cmH2O, CSF white cells 3,200/mm³ (95% neutrophils), protein 2.8 g/L, glucose 1.2 mmol/L (serum glucose 6.1 mmol/L). Gram stain shows Gram-negative diplococci. Which one of the following should be administered immediately after blood cultures are obtained?
A. IV ceftriaxone 2 g and IV dexamethasone 10 mg (Correct Answer)
B. IV benzylpenicillin 2.4 g and IV dexamethasone 10 mg
C. IV ceftriaxone 2 g and IV aciclovir 10 mg/kg
D. IV benzylpenicillin 2.4 g alone
E. IV cefotaxime 2 g and IV vancomycin 1 g
Explanation: ***IV ceftriaxone 2 g and IV dexamethasone 10 mg***
- Third-generation cephalosporins like **ceftriaxone** are the first-line empirical treatment for bacterial meningitis due to their excellent **CSF penetration** and coverage against **Neisseria meningitidis** (Gram-negative diplococci).
- **Dexamethasone** should be administered with or just before the first dose of antibiotics to reduce the **inflammatory response** and decrease the risk of neurological sequelae such as **hearing loss**.
*IV benzylpenicillin 2.4 g and IV dexamethasone 10 mg*
- While effective against meningococci, **benzylpenicillin** is no longer the empirical choice in the hospital setting due to potential **penicillin resistance** in Streptococcus pneumoniae.
- High-dose intravenous penicillin is generally reserved for the **pre-hospital setting** when a purpuric rash is seen and transfer to a hospital is delayed.
*IV ceftriaxone 2 g and IV aciclovir 10 mg/kg*
- **Aciclovir** is used for viral causes like **Herpes Simplex Encephalitis**, but the CSF findings (high neutrophils, low glucose, high protein) clearly indicate a **bacterial etiology**.
- Failure to provide **dexamethasone** in a patient with suspected bacterial meningitis misses an opportunity to reduce potential long-term **morbidity**.
*IV benzylpenicillin 2.4 g alone*
- Administering penicillin alone does not cover the possibility of other bacteria and fails to address the **septic inflammatory response** managed by steroids.
- The absence of **dexamethasone** is contrary to current clinical guidelines which emphasize the prevention of **cerebral edema** and vasculitis.
*IV cefotaxime 2 g and IV vancomycin 1 g*
- This combination is typically used when **resistant pneumococci** are suspected or in regions with high penicillin resistance; however, the Gram stain specifically points to **meningococcus**.
- **Ceftriaxone** 2g twice daily is the standard UK and international recommendation for adult suspected bacterial meningitis; adding **vancomycin** is not routinely required for Gram-negative diplococci.
Question 20: A 34-year-old man from Romania with newly diagnosed smear-positive pulmonary tuberculosis is started on standard four-drug therapy. He has no significant past medical history. After 3 days of treatment, he develops a red, itchy maculopapular rash over his trunk and limbs, with no mucosal involvement or systemic features. His vital signs are normal. Which one of the following is the most appropriate initial management?
A. Continue all anti-tuberculous drugs and add oral antihistamines
B. Stop all anti-tuberculous drugs and rechallenge with each drug individually after the rash resolves (Correct Answer)
C. Continue rifampicin, isoniazid, and ethambutol; stop pyrazinamide
D. Stop all anti-tuberculous drugs and start corticosteroids
E. Continue all anti-tuberculous drugs and add oral corticosteroids
Explanation: ***Stop all anti-tuberculous drugs and rechallenge with each drug individually after the rash resolves***- For a widespread **maculopapular rash** occurring after starting TB therapy, global guidelines recommend stopping all drugs to prevent potential progression to **severe cutaneous adverse reactions (SCARs)** like SJS/TEN.- Once the rash clears, drugs are reintroduced one by one (starting with the least likely culprit, such as **Ethambutol**, then **Isoniazid**, then **Rifampicin**) to identify the specific offending agent.*Continue all anti-tuberculous drugs and add oral antihistamines*- Continuing therapy in the presence of a generalized rash is dangerous as it may lead to **exfoliative dermatitis** or life-threatening hypersensitivity.- **Antihistamines** only mask symptomatic itching and do not address the underlying drug-induced immune response.*Continue rifampicin, isoniazid, and ethambutol; stop pyrazinamide*- Although **Pyrazinamide** is a frequent cause of rash, any of the four drugs could be the culprit, and clinical judgment cannot definitively rule others out without a **structured rechallenge**.- Continuing the other three drugs risks worsening the reaction if the culprit was actually **Isoniazid** or **Rifampicin**.*Stop all anti-tuberculous drugs and start corticosteroids*- **Systemic corticosteroids** are generally reserved for severe reactions with systemic features (DRESS) or mucosal involvement, which this patient lacks.- Stopping the medications should be the first step; routine use of steroids can interfere with the diagnosis of the drug reaction and carries its own side-effect profile.*Continue all anti-tuberculous drugs and add oral corticosteroids*- This approach is incorrect as it risks severe **immunosuppression** in a TB patient and potentially hides a worsening **hypersensitivity reaction**.- Effective management of drug-induced allergy requires the removal of the **offending antigen** rather than attempting to suppress the immune response while the antigen is still present.
